Continue or not to continue? Attitudes towards deprescribing among community-dwelling older adults in China.

Journal Article (Journal Article)

Background

Inappropriate prescribing of medications and polypharmacy among older adults are associated with a wide range of adverse outcomes. It is critical to understand the attitudes towards deprescribing-reducing the use of potentially inappropriate medications (PIMs)-among this vulnerable group. Such information is particularly lacking in low - and middle-income countries.

Methods

In this study, we examined Chinese community-dwelling older adults' attitudes to deprescribing as well as individual-level correlates. Through the community-based health examination platform, we performed a cross-sectional study by personally interviews using the revised Patients' Attitudes Towards Deprescribing (rPATD) questionnaire (version for older adults) in two communities located in Suzhou, China. We recruited participants who were at least 65 years and had at least one chronic condition and one prescribed medication.

Results

We included 1,897 participants in the present study; the mean age was 73.8 years (SD = 6.2 years) and 1,023 (53.9%) were women. Most of older adults had one chronic disease (n = 1,364 [71.9%]) and took 1-2 regular drugs (n = 1,483 [78.2%]). Half of the participants (n = 947, 50%) indicated that they would be willing to stop taking one or more of their medicines if their doctor said it was possible, and 924 (48.7%) older adults wanted to cut down on the number of medications they were taking. We did not find individual level characteristics to be correlated to attitudes to deprescribing.

Conclusions

The proportions of participants' willingness to deprescribing were much lower than what prior investigations among western populations reported. It is important to identify the factors that influence deprescribing and develop a patient-centered and practical deprescribing guideline that is suitable for Chinese older adults.

Full Text

Duke Authors

Cited Authors

  • Tan, J; Wang, M; Pei, X; Sun, Q; Lu, C; Wang, Y; Zhang, L; Wu, C

Published Date

  • June 2022

Published In

Volume / Issue

  • 22 / 1

Start / End Page

  • 492 -

PubMed ID

  • 35676628

Pubmed Central ID

  • PMC9175377

Electronic International Standard Serial Number (EISSN)

  • 1471-2318

International Standard Serial Number (ISSN)

  • 1471-2318

Digital Object Identifier (DOI)

  • 10.1186/s12877-022-03184-3

Language

  • eng